- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
AZ1729 is a short chain fatty acid receptor FFA2 (GPR43) regulator that acts as a direct allosteric agonist and as a positive allosteric modulator (PAM). AZ1729 selectively enhances Gi-mediated signaling (Gi-biased ligand), but not at those transduced by Gq/G11 pathway.
FFA2 (GPR43) regulator that acts as a direct allosteric agonist and as a positive allosteric modulator (PAM); Gi-biased ligand
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | −20°C |
| SMILES string | Fc1ccc(cc1)C(=O)Nc2cc(ccc2)c3[s]c(nc3C)NC(=N)N |
| InChI | 1S/C18H16FN5OS/c1-10-15(26-18(22-10)24-17(20)21)12-3-2-4-14(9-12)23-16(25)11-5-7-13(19)8-6-11/h2-9H,1H3,(H,23,25)(H4,20,21,22,24) |
| InChI key | HULFYSCAJVTAAR-UHFFFAOYSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
¥ 2528.88
-
询价
-
¥ 2814.26
-
¥ 4039.86
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 4390.38
-
询价
-
¥ 10277.12
-
¥ 2151.46
-
¥ 1568.60
-
¥ 2307.00
-
¥ 2132.12
-
¥ 1476.40
-
¥ 2911.61
-
¥ 4476.05
-
¥ 18741.69
微信小程序
7X24小时在线咨询